These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6783152)

  • 21. [Pharmacological study on the bromhexine metabolite ambroxol (author's transl)].
    Püschmann S; Engelhorn R
    Arzneimittelforschung; 1978; 28(5a):889-98. PubMed ID: 581987
    [No Abstract]   [Full Text] [Related]  

  • 22. Ambroxol increases the choline but not fatty acid incorporation into lung phospholipids in experimental lung disorders.
    Wilke A; Müller B; von Wichert P
    Respiration; 1987; 52(2):129-36. PubMed ID: 3671891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incorporation of a stimulant of the synthesis and secretion of pulmonary surfactant (ambroxol) in the medical treatment of serous otitis].
    Calero del Castillo JB; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    An Otorrinolaringol Ibero Am; 1988; 15(2):209-18. PubMed ID: 3389499
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of secretory otitis media with ambroxol].
    Sartoris A
    Acta Otorhinolaryngol Ital; 1987; 7 Suppl 16():51-60. PubMed ID: 3334304
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ambroxol in bronchopulmonary pathology in children].
    Berni M; Collina A; Zavattini G
    Clin Ter; 1983 Sep; 106(5):351-5. PubMed ID: 6641103
    [No Abstract]   [Full Text] [Related]  

  • 26. [The effect of ambroxol on mucociliary clearance (author's transl)].
    Weiss T; Dorow P; Felix R
    Prax Klin Pneumol; 1981 Aug; 35(8):359-62. PubMed ID: 7345432
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long-term treatment of chronic bronchitis with ambroxol].
    Schöpp W
    ZFA (Stuttgart); 1981 Sep; 57(26):1778-86. PubMed ID: 7303838
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical study on Lasolvan in chronic obstructive pulmonary disease.
    Král B; Ellás J; Rozánek P; Jirkal J; Tilser P
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(5):601-6. PubMed ID: 7051260
    [No Abstract]   [Full Text] [Related]  

  • 29. [Incorporation of a stimulant of synthesis and secretion of a pulmonary surfactant (ambroxol) into the treatment of otitis serosa].
    Bautista Calero del Castillo J; Pérez Martínez F; Piqueras Pérez F; Redondo Luciáñez ER
    Acta Otorrinolaringol Esp; 1988; 39(1):61-4. PubMed ID: 3272269
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effectiveness of lasolvan and bromhexine in chronic nonspecific lung diseases].
    Solopov VN; Lunichkina IV; Plisko LF
    Sov Med; 1989; (6):82-4. PubMed ID: 2678522
    [No Abstract]   [Full Text] [Related]  

  • 31. [New concepts in the therapy of mucostasis].
    von Seefeld H; Weiss JM; Rensch H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():896-900. PubMed ID: 6689074
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of lacrimal gland improvement by NA-872 in Sjögren's syndrome.
    Manthorpe R; Frost-Larsen K; Isager H; Prause JU
    Acta Ophthalmol (Copenh); 1981 Jun; 59(3):428-9. PubMed ID: 7034455
    [No Abstract]   [Full Text] [Related]  

  • 33. Response to surfactant activator (ambroxol) in alveolar proteinosis.
    Diaz JP; Manresa Presas F; Benasco C; Guardiola J; Munoz L; Clariana A
    Lancet; 1984 May; 1(8384):1023. PubMed ID: 6143950
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacodynamic mechanism and therapeutic activity of ambroxol in animal experiments.
    Disse BG; Ziegler HW
    Respiration; 1987; 51 Suppl 1():15-22. PubMed ID: 3602598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of prostaglandin E1 on pulmonary circulation and oxygen delivery in patients with adult respiratory distress syndrome].
    Tokioka H; Kobayashi O; Saeki S; Maeda N; Ohta Y; Kosaka F
    Kokyu To Junkan; 1984 May; 32(5):519-21. PubMed ID: 6540890
    [No Abstract]   [Full Text] [Related]  

  • 36. The role of alveolar macrophages in surfactant turnover. An experimental study with metabolite VIII of bromhexine (Ambroxol).
    Eckert H; Lux M; Lachmann B
    Lung; 1983; 161(4):213-8. PubMed ID: 6688451
    [No Abstract]   [Full Text] [Related]  

  • 37. [Synthesis of water-soluble metabolites of cholin and incorporation of choline in phosphatidylcholine in the lungs of normal and ambroxol-pretreated rabbits].
    Reissmann H; Wiegers U; Meyer-Ingold W; von Wichert P
    Prax Klin Pneumol; 1984 Mar; 38(3):104-7. PubMed ID: 6326074
    [No Abstract]   [Full Text] [Related]  

  • 38. Pumpless extracorporeal removal of carbon dioxide combined with ventilation using low tidal volume and high positive end-expiratory pressure in a patient with severe acute respiratory distress syndrome.
    Bein T; Zimmermann M; Hergeth K; Ramming M; Rupprecht L; Schlitt HJ; Slutsky AS
    Anaesthesia; 2009 Feb; 64(2):195-8. PubMed ID: 19143699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect on the mucociliary clearance of ambroxol administered via inhalation: preliminary observations].
    Olivieri D; Del Donno M; Annicelli A; Palmieri F
    Arch Monaldi; 1983; 38(4):135-40. PubMed ID: 6679252
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative evaluation of the effectiveness of lasolvan and mucodine in chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Sov Med; 1988; (5):69-72. PubMed ID: 3062806
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.